Ultra pH-sensitive polymeric nanovesicles co-deliver doxorubicin and navitoclax for synergetic therapy of endometrial carcinoma-Reference-Cited by-同舟云学术

Ultra pH-sensitive polymeric nanovesicles co-deliver doxorubicin and navitoclax for synergetic therapy of endometrial carcinoma

Published:2020 Issue:8 Volume:8 Page:2264-2273
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Ding Jie¹²³⁴,Zhang Xu¹²³⁴,Chen Chuangqi⁵⁶⁷⁴,Huang Yuqiang⁵⁶⁷⁴,Yu Xingsu⁵⁶⁷⁴,Li Xiaomao¹²³⁴^ORCID

Affiliation:

1. Department of Gynecology and Obstetrics

2. The Third Affiliated Hospital of Sun Yat-sen University

3. Guangzhou 510630

4. China

5. Reproductive Center

6. Guangdong Women's Health Care Center

7. Guangzhou 511400

Abstract

An ultra pH-sensitive polymeric nanovesicle was constructed to co-deliver doxorubicin and navitoclax for highly efficient synergetic treatment of endometrial carcinoma.

Funder

Science and Technology Planning Project of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/BM/D0BM00112K

Reference38 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Tumor progression, metastasis, and modulators of epithelial–mesenchymal transition in endometrioid endometrial carcinoma: an update

3. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis

4. Treatment options for advanced endometrial carcinoma

5. The clinical management of inoperable endometrial carcinoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial peptide-modified pH-sensitive micelles against pneumonia caused by methicillin-resistant Staphylococcus aureus;Journal of Drug Delivery Science and Technology;2024-09

2. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23

3. Impact of Stimuli-Responsive Biomaterials in Gynecological Cancer Therapy;Biomedical Materials & Devices;2023-11-06

4. Nanocarrier-based targeting of metabolic pathways for endometrial cancer: Status and future perspectives;Biomedicine & Pharmacotherapy;2023-10

5. Recent Advances in Senotherapeutics Delivery;Tissue Engineering Part B: Reviews;2022-12-01